Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

biosimilar collaborations ireland limited - insúlín aspart - sykursýki - lyf notuð við sykursýki - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - sodium cromoglicate - augndropar, lausn - 20 mg/ml

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - fluconazolum inn - hart hylki - 150 mg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 0,5 mg/ml

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 2 mg/ml

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 50 míkróg/ml

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - methotrexatum inn - tafla - 2,5 mg

Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - sykursýki - lyf notuð við sykursýki - meðferð sykursýki.